← FDA DRUG APPROVALS

FDA ANDA · ANDA075273

KETOCONAZOLE

Sponsor: TEVA

APPLICATION
ANDA075273
TYPE
ANDA
ORIGINAL APPROVAL
1999-06-15
LATEST ACTION
2023-08-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

KETOCONAZOLEDiscontinued
KETOCONAZOLE 200MG · TABLET · ORAL

Approval history

2023-08-16Labeling · Supplement 20 · standardAP
2020-02-28Labeling · Supplement 18 · standardAP
2017-11-15Labeling · Supplement 16 · standardAP
2017-10-25Labeling · Supplement 14 · standardAP
2017-10-25Labeling · Supplement 15 · standardAP
2001-09-05Manufacturing (CMC) · Supplement 2AP
2001-08-30Manufacturing (CMC) · Supplement 3AP
2000-07-07Manufacturing (CMC) · Supplement 1AP
1999-06-15OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →